Great Lakes Drug Development, Inc. Report issue

For profit Phase 2 Phase 3
Founded: Brighton MI United States (2008)
Status: Acquired by Certara (2013)

Organization Overview

First Clinical Trial
2008
NCT00817414
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Great Lakes Pharmaceuticals Inc.

Active Ingredients

Drugs in Phase 3 Trials (1)

heparin (liquaemin) (1 trial)

Drugs in Phase 2 Trials (2)

eplerenone (inspra) (1 trial)

osilodrostat (Isturisa) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hypertension (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 3